| |
|
|
|
Anavex Life Sciences Corp.  
|
|
2.79 0.04 (0.01%) |
08-14 16:00 |
|
Open: |
2.75 |
Pre close: |
2.75 |
Target:
|
3.61
|
|
High: |
2.85 |
Low: |
2.74 |
Resistance:
|
3.09
3.42
|
|
Volume: |
132,161 |
Market Cap: |
127M |
Support:
|
2.56
2.13
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.81
 |
MACD |
MACD(12,26):
|
-0.11 |
|
MA(20): |
2.87  |
Signal(12,26,9): |
-0.13 |
|
MA(100): |
2.86 |
Stochastic Oscillator |
%K(14,3):
|
34.92 |
|
MA(250): |
3.31 |
%D(3): |
35.21 |
|
Average Volume(K) |
3-Month: |
76162
|
52-Week |
High:
|
5.15 |
|
10-Days: |
29842 |
Low: |
1.85 |
|
RSI |
RSI(14):
|
44.67 |
Change(%): |
-27.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.410 |
Return on Equity (ttm) |
-79.9 |
Shares Out. (M) |
45.43 |
|
EPS Est. Current Year |
-0.370 |
Return on Assets (ttm) |
-71.0 |
Shares Float (M) |
35.29 |
|
EPS Est. Next Year |
-0.450 |
PEG Ratio |
0.00 |
% Held by Insiders |
22.70 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
22.50 |
|
Forward EPS |
-0.480 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
5619 |
|
Book Value (p.s.) |
5.540 |
EBITDA (p.s.) |
-0.204 |
P/E |
-6.85 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.51 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.48 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-4.22 |
P/CF |
-13.47 |
|
|
|
|
|
|
